Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2010-9-13
pubmed:abstractText
The compulsive gnawing (CG) test has been used for numerous years as an assay to determine the dopaminergic activity of various compounds. We developed a new method of quantification via a digitization step which allowed a more precise measurement of the gnawing activity. It was the aim of the present study to explore possible dopaminergic effects of salvinorin A (SA), the major active compound of Salvia divinorum, using the new digitized CG test. A group of experiments using male C57BL/6 mice were performed to validate the new method of quantification showing only significant increases of gnawing when the dopamine reuptake inhibitors buproprion (20 mg/kg, p.0.) and nomifensine (10?mg/kg, i.p.) were given concomitantly with apomorphine (10?mg/kg, i.p.). Different concentrations of the SA (1.0, 2.5, 5, and 10?mg/kg, i.p.) were tested with positive dopaminergic activity when administered with apomorphine which differed from the semisynthetic counterpart U-69593. Furthermore, the activity observed with SA was unsuccessfully antagonized by the ?-opioid receptor antagonist norbinaltorphimine (NorBNI; 10 and 20?mg/kg, i.p.), while the dopamine antagonist haloperidol did successfully block (0.06?mg/kg, i.p.) the gnawing activity seen with SA. Our data further strengthen the argument that salvinorin A is not a selective ?-opioid receptor agonist and is the first in vivo study that veers from salvinorin A acting solely like its synthetic counterparts. Furthermore, the digitized CG test system used in this study provides a new computational method to accurately detect behavior associated with dopaminergic neurotransmission.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1439-0221
pubmed:author
pubmed:copyrightInfo
© Georg Thieme Verlag KG Stuttgart-New York.
pubmed:issnType
Electronic
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1405-10
pubmed:meshHeading
pubmed-meshheading:20217638-Analog-Digital Conversion, pubmed-meshheading:20217638-Animals, pubmed-meshheading:20217638-Behavior, Animal, pubmed-meshheading:20217638-Compulsive Behavior, pubmed-meshheading:20217638-Disease Models, Animal, pubmed-meshheading:20217638-Diterpenes, Clerodane, pubmed-meshheading:20217638-Dopamine Agonists, pubmed-meshheading:20217638-Dopamine Uptake Inhibitors, pubmed-meshheading:20217638-Dose-Response Relationship, Drug, pubmed-meshheading:20217638-Male, pubmed-meshheading:20217638-Mastication, pubmed-meshheading:20217638-Mice, pubmed-meshheading:20217638-Mice, Inbred C57BL, pubmed-meshheading:20217638-Motor Activity, pubmed-meshheading:20217638-Narcotic Antagonists, pubmed-meshheading:20217638-Plant Extracts, pubmed-meshheading:20217638-Receptors, Opioid, kappa, pubmed-meshheading:20217638-Salvia
pubmed:year
2010
pubmed:articleTitle
A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo.
pubmed:affiliation
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida 32610-0494, USA.
pubmed:publicationType
Journal Article, Validation Studies